Excerpt from:
Hillstream BioPharma to Present at the Virtual Sidoti Micro-Cap Conference on January 18-19, 2023
Category Archives: Global News Feed
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer
NFL Biosciences: Financial calendar for the first half of 2023
Read the rest here:
NFL Biosciences: Financial calendar for the first half of 2023
Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis due to NASH
BioCorRx Partners with Government Plus to Expand its Beat Addiction Recovery Program in the United States
Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
Go here to see the original:
Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting Shares. Common Shares Trading on CSE Unaffected
Nurix Therapeutics Announces Webcast to Review Data from its Phase 1 Clinical Trial of BTK Degrader, NX-2127, Presented at the 64th American Society…
VALNEVA – Declaration of shares and voting rights: October 31, 2022
Originally posted here:
VALNEVA - Declaration of shares and voting rights: October 31, 2022
Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single…
MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
UPDATE – scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop…
Supernus Provides Regulatory Update on SPN-830
Read the original here:
Supernus Provides Regulatory Update on SPN-830
invIOs to present at upcoming industry and investor conferences
Read more from the original source:
invIOs to present at upcoming industry and investor conferences